glp 1 dual agonist The Emerging Role of GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Trends in the Development of
Description
1997;273(5):E981-E988

By the numbers Pillsbury has applied for federal funding to study the effects of GLP-1s on immune response

Trulicity (dulaglutide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Trulicity has been named in both MDL 3094 and MDL 3163 and appears in approximately one quarter of the federal GLP-1 drug lawsuits reviewed by USA TODAY

But side effects are common when starting treatment or moving up to a higher dose

Emergence of Oral GLP-1 Agonists: Oral versions like Rybelsus are gaining popularity for improved patient adherence

doi: 10.1038/s41467-022-28683-0 [DOI] [PMC free article] [PubMed] [Google Scholar] 216.Scheen AJ, Lefbvre PJ
